These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3280130)

  • 1. Structure determination of Cryptococcus neoformans serotype A-variant glucuronoxylomannan by 13C-n.m.r. spectroscopy.
    Cherniak R; Jones RG; Reiss E
    Carbohydr Res; 1988 Jan; 172(1):113-38. PubMed ID: 3280130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucuronoxylomannan of Cryptococcus neoformans serotype B: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy.
    Turner SH; Cherniak R
    Carbohydr Res; 1991 Apr; 211(1):103-16. PubMed ID: 1773425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy.
    Turner SH; Cherniak R; Reiss E; Kwon-Chung KJ
    Carbohydr Res; 1992 Sep; 233():205-18. PubMed ID: 1446309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type-specific polysaccharides of Cryptococcus neoformans. n.m.r.-spectral study of a glucuronomannan chemically derived from a Tremella mesenterica exopolysaccharide.
    Cherniak R; Jones RG; Slodki ME
    Carbohydr Res; 1988 Nov; 182(2):227-39. PubMed ID: 3072079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay.
    Belay T; Cherniak R
    Infect Immun; 1995 May; 63(5):1810-9. PubMed ID: 7537249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the 13C-enriched O-deacetylated glucuronoxylomannan of Cryptococcus neoformans serotype A determined by NMR spectroscopy.
    Sheng S; Cherniak R
    Carbohydr Res; 1997 Jun; 301(1-2):33-40. PubMed ID: 9228737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assimilation of xylose, mannose, and mannitol for synthesis of glucuronoxylomannan of Cryptococcus neoformans determined by 13C nuclear magnetic resonance spectroscopy.
    Cherniak R; O'Neill EB; Sheng S
    Infect Immun; 1998 Jun; 66(6):2996-8. PubMed ID: 9596780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural studies of the capsular polysaccharide of a non-neoformans Cryptococcus species identified as C. laurentii, which was reclassified as Cryptococcus flavescens, from a patient with AIDS.
    Ikeda R; Maeda T
    Carbohydr Res; 2004 Feb; 339(3):503-9. PubMed ID: 15013387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy.
    Bacon BE; Cherniak R; Kwon-Chung KJ; Jacobson ES
    Carbohydr Res; 1996 Mar; 283():95-110. PubMed ID: 8901265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies.
    Todaro-Luck F; Reiss E; Cherniak R; Kaufman L
    Infect Immun; 1989 Dec; 57(12):3882-7. PubMed ID: 2680986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans serotype C as determined by 2D 1H NMR spectroscopy.
    Bacon BE; Cherniak R
    Carbohydr Res; 1995 Oct; 276(2):365-86. PubMed ID: 8542606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity.
    Devi SJ; Schneerson R; Egan W; Ulrich TJ; Bryla D; Robbins JB; Bennett JE
    Infect Immun; 1991 Oct; 59(10):3700-7. PubMed ID: 1716613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of a
    Hargett AA; Azurmendi HF; Crawford CJ; Wear MP; Oscarson S; Casadevall A; Freedberg DI
    Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2315733121. PubMed ID: 38330012
    [No Abstract]   [Full Text] [Related]  

  • 14. Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans.
    Cherniak R; Morris LC; Anderson BC; Meyer SA
    Infect Immun; 1991 Jan; 59(1):59-64. PubMed ID: 1987064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dectin-3 Recognizes Glucuronoxylomannan of
    Huang HR; Li F; Han H; Xu X; Li N; Wang S; Xu JF; Jia XM
    Front Immunol; 2018; 9():1781. PubMed ID: 30131805
    [No Abstract]   [Full Text] [Related]  

  • 16. Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network.
    Cherniak R; Valafar H; Morris LC; Valafar F
    Clin Diagn Lab Immunol; 1998 Mar; 5(2):146-59. PubMed ID: 9521136
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Kuttel MM; Casadevall A; Oscarson S
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32517333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the mannan backbone of cryptococcal glucuronoxylomannan and a glycolytic enzyme of Staphylococcus aureus to contact-mediated killing of Cryptococcus neoformans.
    Ikeda R; Saito F; Matsuo M; Kurokawa K; Sekimizu K; Yamaguchi M; Kawamoto S
    J Bacteriol; 2007 Jul; 189(13):4815-26. PubMed ID: 17483230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans.
    Brandt S; Thorkildson P; Kozel TR
    Clin Diagn Lab Immunol; 2003 Sep; 10(5):903-9. PubMed ID: 12965925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of a hexasaccharide, the repeating unit of O-deacetylated GXM of C. neoformans serotype A.
    Zhang J; Kong F
    Carbohydr Res; 2003 Aug; 338(17):1719-25. PubMed ID: 12892938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.